Expression of B7-H3 (CD276) in surgically resected esophageal squamous cell carcinoma.

医学 阶段(地层学) 免疫组织化学 比例危险模型 食管癌 病态的 胃肠病学 癌症 癌 病理 内科学 肿瘤科 生物 古生物学
作者
Yuta Maruki,Atsuo Takashima,Takahiro Miyamoto,Hidekazu Hirano,Hirokazu Shoji,Yoshitaka Honma,Satoru Iwasa,Natsuko Okita,Ken Kato,Shigeki Sekine,Kazuo Koyanagi,Hiroyuki Daiko,Shigehisa Kitano,Kazunori Aoki,Narikazu Boku
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:36 (4_suppl): 70-70 被引量:1
标识
DOI:10.1200/jco.2018.36.4_suppl.70
摘要

70 Background: B7-H3 (also known as CD276) belongs to a family of immune modulators that includes PD-1 and PD-L1 (also known as B7-H1 or CD274), which has been reported to be expressed in many carcinomas and associated with poor prognosis. In this study, we explored the relationship between B7-H3 expression and clinical background and prognosis of esophageal squamous cell carcinoma (ESCC) patients treated with surgery alone. Methods: The subjects of this study was the ESCC patients who received curative surgery between January 2009 and December 2014 without prior treatment, excluding T4 and M1 disease. We evaluated tumor B7-H3 expression by immunohistochemistry, which was scored to 0 (absent) if < 10% of cancer cells were stained, and 1 (weak), 2 (moderate), or 3 (strong) according to the intensity in stained cancer cells (> 10%). The B7-H3 expression of score 2 and 3 was regarded as positive. We compared the clinical characteristics and prognosis between B7-H3 positive and negative patients using log rank test and Cox proportional hazards regression analysis for adjusting the backgrounds. Results: 33 (45%) of 74 patients were positive for expression of B7-H3. Between H7-H3 (+) and (-) groups, there were difference in pathological T stage (pT1/pT2/pT3: 9/0/24 vs. 23/4/14, p < 0.01) and lymph vessel invasion (+/-: 7/26 vs. 17/24, p=0.08). There was no association between sex, age, N factor, and vascular invasion. B7-H3 (+) patients showed trend of poor recurrence free survival (RFS) and overall survival, not significant, (HR=1.41[95%CI:0.63-3.14] p=0.41 for RFS, HR=1.34[ 95%CI:0.52-3.48] p=0.55 for OS). However B7-H3 status was not a prognostic factor in multivariate analysis (HR=0.78[95% CI: 0.33-1.85] for RFS, HR=0.73 [ 95%CI:0.26-2.02] for OS). Conclusions: The expression ratio of B7-H3 was observed in 45% of the esophageal cancer, which was related with T stage and lymphatic vessel invasion but not with clinical outcomes such as RFS and OS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
墨羽发布了新的文献求助10
1秒前
Charles完成签到,获得积分10
1秒前
2秒前
绿鲤鱼完成签到,获得积分10
2秒前
嘻嘻发布了新的文献求助30
2秒前
踏实以松发布了新的文献求助10
3秒前
每天100次完成签到,获得积分10
3秒前
烽火发布了新的文献求助10
3秒前
4秒前
BBridge完成签到 ,获得积分10
4秒前
小蘑菇的应助被尼克狐尼克采纳,获得10
6秒前
哈哈哈发布了新的文献求助10
6秒前
李健的应助被黄姗姗采纳,获得10
6秒前
司空蓝发布了新的文献求助10
6秒前
像大树一般舒展完成签到,获得积分20
7秒前
7秒前
大里完成签到 ,获得积分10
8秒前
lirongcas完成签到,获得积分10
8秒前
FFF完成签到 ,获得积分10
8秒前
张伟发布了新的文献求助10
9秒前
9秒前
9秒前
June完成签到 ,获得积分10
10秒前
ke发布了新的文献求助10
10秒前
小刘的应助被zgw采纳,获得10
10秒前
12秒前
芋泥脑袋完成签到,获得积分10
12秒前
鱼鱼发布了新的文献求助10
12秒前
12秒前
Xu完成签到,获得积分10
13秒前
复杂蜜蜂完成签到,获得积分10
13秒前
chenyu完成签到,获得积分10
14秒前
哈哈哈发布了新的文献求助10
15秒前
make完成签到 ,获得积分10
15秒前
Lucas的应助被CTbnun采纳,获得10
16秒前
觞酌的应助被zc采纳,获得10
16秒前
17秒前
变形金刚发布了新的文献求助10
18秒前
耳东陈发布了新的文献求助10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186012
求助须知:如何正确求助?哪些是违规求助? 9574616
关于积分的说明 21837084
捐赠科研通 7783730
什么是DOI,文献DOI怎么找? 3434729
关于科研通互助平台的介绍 2559055
邀请新用户注册赠送积分活动 2481504